The X-chromosome from the CBA/N mouse which carries the defective Bruton's tyrosine kinase (Btk) allele (X xid ) has been introgressively backcrossed onto the plasmacytoma (PCT) inductionsusceptible BALB/cAN. Inbred BALB/c.CBA/N-xid/xid (C.CBA/N) mice raised and maintained in our conventional colony were given three 0.5 ml injections of pristane and were highly refractory to PCT induction. Only one PCT was found among 59 mice followed for ജ300 days. Twenty mice were examined at day 200 for foci of plasma cells in the oil granuloma. Ten mice had small foci of plasma cells, most of which were plasmacytotic, embedded in the inflammatory oil granuloma. In one there were multiple foci, but most of the mice had only one or two foci. F 1 hybrid X xid Y males derived from CBA/N females crossed to BALB/cAnPt were also resistant to PCT induction, while heterozygous and homozygous XY males were susceptible. C.CBA/N mice can develop extensive mucosal plasma cells as well as plasma cell accumulations in oil granuloma tissue, but the precursors of these plasma cells do not give rise to PCT in genetically susceptible hosts. The failure of C.CBA/N mice to develop PCT is probably due to the elimination of B cell clones that can be perpetuated by repeated exposure to thymus-independent type 2 antigens.
Introduction
In 1993 the genes for XLA (X-linked agammaglobulemia) in humans and xid (X-linked immunodeficiency) in mice were cloned and sequenced, and found to code for a non-receptor protein tyrosine kinase Bruton's agammaglobulinemia tyrosine kinase (Btk) (1) (2) (3) (4) . The wild-type gene product was in the Btk/Tec subfamily of src kinases that contained pleckstrin homology (PH), TH (Tec), SH2, SH3 and kinase domains (5) . The xid mutation in the mouse produces a critical Arg to Cys replacement in the PH domain that blocks the activation of this kinase and its subsequent effector functions, leading to DNA synthesis (6, 7) , cell cycle completion in B cells and induction of anti-apoptotic proteins (8) (9) (10) (11) .
In humans the XLA mutations produce a severe immunodeficiency, a developmental arrest in the pre-B stage, and a loss of peripheral B cells and plasma cells (12) . In the Correspondence to: M. Potter Transmitting editor: J. F. Kearney Received 18 November 1998, accepted 12 March 1999 mouse the xid mutation is associated with defective immune responses to thymus-independent type 2 antigens (TI-2) (see reviews in 13, 14) . B cells that recognize the polyvalent TI-2 antigens are activated into DNA synthesis and cell division by cross-linking the sIgM receptors (B cell receptor). Most of these antigen-antibody interactions are associated with low binding affinities and polyreactivity (15) . The epitopes on TI-2 antigens are widely distributed in nature and thus can be of autogenous origin (16) , many are polysaccharides (13) . Subsets of mature peripheral B cells that react to TI-2 antigens in the mouse are characterized by an IgM high , IgD low , B220 low , CD5 ϩ or CD5 -phenotype, and are located in the peritoneal cavity (PerC) and spleen (17) . These B cells are commonly called B-1 cells, are thought to develop predominantly from fetal hematopoietic stem cells and are produced de novo until mice are~30 days of age (15, 18) . Thereafter they are maintained by self-renewal of V H D H J H /V L J L rearranged cells (19) (20) (21) . In adult mice B cell lymphocytopoiesis is from de novo differentiation of hematopoietic stem cells from the bone marrow (19) . The self renewal process and maintenance of B-1 cells in the mouse requires signaling through the B cell receptor (22) . Peritoneal plasmacytomas (PCT) are induced in genetically susceptible BALB/cAn mice by several different kinds of materials: solid plastic objects (23, 24) , paraffin oils, e.g. pristane (2,6,10,14 tetramethylpentadecane) (25) , and silicone gels (26) . The pristane model of plasmacytomagenesis has been the most extensively studied. Pristane is injected into the peritoneal space where it induces the formation of chronic oil granulomatous tissue, the microenvironment where PCT develop morphologically (27, 28) . PCT formation is usually preceded by the appearance of foci of proliferating plasma cells (28) . Over 95% of the PCT have consistent chromosomal translocations that activate the c-myc oncogene, of which~80% are T(12;15) and are 10-15% T(6;15) (see review in 29). All PCT so far studied appear to have a second consistent tumor suppressor-like mutation as they do not express functional transforming growth factor-β receptors (30) . The development of the PCT in peritoneal chronic inflammatory tissues raises the question about the relationship of B-1 lymphocytes to PCT development. The availability of an inbred BALB/c.CBA/N congenic strain that is homozygous for the defective Btk xid on a PCT induction-susceptible BALB/ cAn background has provided the opportunity to determine if this defect affects pristane-induced peritoneal plasmacytomagenesis. In the present study we have attempted to induce PCT in BALB/cAn.CBA/N-xid/xid mice with pristane and found these mice to be highly resistant to PCT induction despite morphological evidence that abundant plasma cells develop in these mice.
Methods
The BALB/cAn.CBA/N-xid /xid (C.CBA/N) strain was originated by a breeding strategy that permitted the introduction of the CBA/N X chromosome onto a different inbred background (31) . Essentially, CBA/N-xid/xid females were mated to BALB/c to obtain F 1 hybrid males X xid Y, which were then mated back to CBA/N to obtain backcross X xid X xid female progeny. These homozygous females were then mated to BALB/cAn to continue the introgressive backcrossing and the process repeated for 20 generations. In this scheme autosomal crossing over occurs, but there is no opportunity for crossing over between BALB/c and CBA/N X chromosomes. This raises the possibility that other PCT resistance genes of CBA X-chromosomal origin could also be introduced in these congenics. This congenic strain made by 20 introgressive backcrosses was then converted to a homozygous strain. C.CBA/N mice were introduced into our AAALAC approved barrier-protected conventional mouse colony at PerImmune (Rockville, MD) and continuously inbred. All mice were maintained on Purina Mouse Chow 5001 (PMI Feeds, St Louis, MO) and acidified tap water ad libitum. The mice were housed in shoe-box-type cages, four to five mice per cage. The bedding used in cages contained cedar shavings Table 1 ). Gp-1 and Gp-2 refer to (Group 1) the 20 female mice autopsied on day 201, and (Group 2) the 10 males and 10 females autopsied on day 303. The controls were BALB/ cAnPt control mice from eight experiments run during the period when the CBA/N studies were carried out. The mean incidence in the BALB/cAnPt controls at day 300 was 45%; however, the mean incidence for the individual experiments ranged from 30 to 60%. In three experiments carried to day 330 the incidence ranged from 45 to 60%.
to control for mites. The colony harbors common potential pathogens such as Sendai virus, Mouse Hepatitis Virus and pin worms.
Pristane was purchased from Aldrich (Milwaukee, WI). To induce PCT the mice were injected with three 0.5 ml doses given i.p. on days 0, 60 and 120 performed under Animal Use Protocol no. 190. After day 120 ascites or peritoneal exudate was aspirated with 25 gauge needles every 3 weeks. Cytofuge preparations were made and the cells were stained with Wright's Giemsa stain. Plasmacytomas were diagnosed by finding ജ10 atypical plasma cells per slide. In most cases two diagnoses per mouse were made. In most fully developed PCT the cytofuge reparations contained Ͼ100 PCT cells. When the mice were autopsied, the mesenteric and omental tissues were excised in large blocks after stripping away the intestines. These were then cut after fixation in Fekete's modification of Tellyesniczky's fixative (70% ethanol:formalin:glacial acetic acid in 20:2:1 parts) into 2-10 mm fragments. All of the 4 µm sections were stained with hematoxylin & eosin and scanned for the presence of plasmacytic foci or PCT. Selected cases were immunostained to determine the heavy chain class by methods previously described (28) .
Results
C.CBA/N mice male and female mice were injected with pristane on days 0, 60 and 120. Of the 79 mice, 20 were autopsied on day 201, another 20 on day 303, and the remaining 39 mice were watched until day 397 for the development of ascites and the appearance of PCT cells in ascites, and then examined for evidence of plasmacytoma- a A total of 22 foci were found; most were typical of the one shown in Fig. 2(D) . One mouse had seven plasmacytotic foci; one mouse had a plasmacytotic and an atypical focus; one mouse had a single atypical focus.
b This mouse had multiple plasmacytotic foci. genesis (Table 1 and Fig. 1 ). Tissue sections of the mesenteric and omental oil granuloma were surveyed for the presence of plasma cells, PCT and foci which contained aggregates of ജ50 plasma cells (Fig. 2) . Foci that contained differentiated plasma cells with round nuclei were classified as plasmacytotic foci (32) (Fig. 2B and D) . Some of these that were still present when the tissue blocks were recut, stained for IgA. In contrast, the plasma cells in foci that contained atypical plasma cells (atypical foci) were larger in size and hyperchromatic, had more irregular nuclei, and resembled the plasma cells in fully developed PCT (Fig. 2A) . The oil granulomatous tissue at 200 days was highly cellular with many macrophages, neutrophils and fibroblasts, and was typical of the inflammatory phase of oil granuloma development in BALB/cAn mice. By day 300 and after, the oil granulomata became progressively more sclerotic and calcified after 300 days. IgA cells were seen scattered through the granulomatous tissues and were abundant in the lamina propria sections of the gut of xid mice (Fig. 2C) . IgA immunostained plasma cells in the lamina propria in ileal villi were counted. Only profiles of villi that included the base (crypt) and tip of the villus were used. (Fig. 2B ) and in one, seven plasmacytotic foci were found. Two atypical foci were seen ( Fig. 2A) : one mouse had a single focus of atypical plasma cells and in the other the atypical focus was associated with a plasmacytotic focus. One mouse in the day 303 sample had multiple foci of differentiated plasma cells. A single advanced PCT was found at day 351; the cells in this tumor were atypical IgA-secreting plasma cells characteristic of PCT and extensively invaded the oil granulomatous tissue. Control BALB/cAnPt mice that were given similar doses of pristane from eight different experiments run during the same period as the C.CBA/N mice developed an overall incidence of 46% PCT (range 30-62.5%) by day 300. The results indicate that C.CBA/N mice were highly refractory to PCT induction by a potent PCT induction regimen but were able to develop typical oil granulomatous tissue that contained plasma cells and focal accumulations of plasma cells.
We previously found that CBA-T6/T6 and (CBA-T6/ T6ϫBALB/c)F 1 mice were resistant to PCT induction by pristane, indicating that CBA-T6/T6 carries strong resistance genes (33) . To determine if the C.CBA/N congenic mouse carried PCT resistance genes other than xid, C.CBAN mice were reciprocally crossed with BALB/cAnPt (Table 1 and Fig. 3) and injected with pristane. The X xid Y males were resistant and resembled C.CBA/N males. XY males were the most susceptible. The high incidence of PCT in the XY males indicates that autosomal CBA/N resistance genes were not present in the C.CBA/N strain. The XX xid and X xid X females developed an intermediate incidence of PCT, 43 and 36% respectively. This partial resistance could be due to additional resistance genes on the CBA/N X xid chromosome or to the effects of the X xid chromosome. Our studies cannot distinguish between these two possibilities.
Discussion
BALB/cAnCBA/N (xid/xid) mice are resistant to PCT induction by three 0.5 ml doses of pristane. Only one PCT was found among 59 mice followed for 300-397 days. To determine if the C.CBA/N congenic might carry autosomal resistance genes to PCT induction, BALB/cAnPt males were crossed to C.CBA/N and the F 1 hybrid males (X xid Y) were again found to be resistant to PCT induction, while the females (X xid X, XX xid ) showed a substantial but partial susceptibility (36-43%). Overall, the results did not indicate the presence of autosomal resistance genes of CBA/N origin. The possibility of another weak PCT resistance gene on the X chromosome of CBA/N origin, however, could not be ruled out. The results indicate the Btk xid gene was principally responsible for the resistance to PCT induction.
Histological studies revealed an abundance of plasma cells in the lamina propria of the intestinal villi. Further, the oil granulomatous tissues examined at day 200 contained isolated plasma cells and in 10 of 20 mice at day 200 plasmacytotic foci were found, i.e. aggregates of ജ50 plasma cells. Thus, plasma cell formation can occur in these immunodeficient mice at the very sites where plasma cells undergo progression to neoplasia.
How can the resistance to PCT induction in C.CBA/N mice be explained? The basic explanation is that the B lymphocyte precursors of PCT in wild-type BALB/cAn mice are missing in xid mice because of developmental clonal elimination mechanisms resulting from defective Btk activation.
The defective xid allele has been reported to interfere with the transmission of signals for DNA synthesis and completion Table 1 ).
of the cell cycle in response to antigen receptor cross-linking by TI-2 antigens (7, 22) . Although B cells from xid mice do respond weakly to B cell receptor cross-linking and enter the G 1 phase, they fail to activate cyclin/cdk kinases (7) and complete the cell cycle (6) . In addition, Btk-deficient cells do not up-regulate the anti-apoptotic proteins Bcl-2 (10) and Bclx L (6, 34) . Thus, B cells in xid mice which respond to crosslinking of their BCR via natural TI-2 antigens could become arrested in the cell cycle, trigger the apoptotic machinery and be eliminated as described and suggested by several studies (6, 7, 9, 10 ).
An alternative way to explain how the xid mutation modifies the development of B cells is that all of the B cells produced in a xid mouse that reach the periphery are short lived and rapidly eliminated. In a recent re-evaluation of the effects of xid on B cell development, Klaus et al. (35) have provided evidence that all B cell compartments may be affected. This suggests the possibility that B cells in xid mice could produce only short-lived B cells and little long-term memory.
Specifically, then, does the xid mutation interfere with the clonal longevity in B-2 lymphocytes that are activated by Tdependent antigens? This question cannot yet be definitively answered. There is evidence that T-dependent responses in conventional B-2 cells are reduced in CBA/N mice (36) (37) (38) (39) (40) . When thymus-dependent immune responses were induced in (CBA/NϫC57BL/6)F 1 hybrids, Ridderstad et al. (39) found a 10-fold reduction in the primary responses in the male (X xid Y) progeny, but qualitatively and quantitatively wild-type (normal) secondary responses. In other studies the btk xid mutation interfered with the formation of long-lived cells; however, the deficit in older mice was much reduced, indicating there was a recovery or a compensating B cell replacement mechanism in old xid mice (38) .
One of the cardinal defects in xid mice is a deficiency of a subset of B cells that react to TI-2 antigens (i.e. B-1 cells).
TI-2 antigens are of autogenous origin as well as being common antigens in ubiquitous microbial species. Thus, B-1 cells, which are self-replenishing (20, 41) and activated naturally by these antigens, are clones that may have undergone repeated cycles of antigen activation and quiescence. Examples of clonal expansions of CD5 ϩ clones have been described in NZB mice (42) . Other direct evidence that clonal longevity exists is found in autoimmune mice where clonal history can be traced through Ig somatic hypermutation (43, 44) . This accumulation of successive Ig somatic mutations is assumed to result from repeated interactions with autoantigens and each mutation may occur in daughter cells of an original clone, separated in space and time. When the xid mutation was introduced into (NZWϫNZB)F 1 hybrid mice, it was found that immune complex glomerulonephritis and anti-DNA antibodies were dramatically reduced (45) , suggesting that clonal evolution did not occur. If a similar process of repeated antigenic exposure occurs in BALB/cAn mice, then it becomes possible that a single clone could accumulate mutations affecting proliferative behavior (oncogenic diversification).
B-1 cells have been reported to be prone to develop clonal expansions both in autoimmune NZB (42) and C57BL/6 mice (46). This phenomenon may be linked to the self-renewing capabilities of B-1 cells in the mouse. The findings in the present study strongly suggest that the reduction in B cells that can respond to TI-2 antigens eliminates the lymphocytic precursors of the PCT cells. These appear to be B-1 cells.
